
Singapore skyline at night. The Muslim Times has the best collection of articles for the war against Covid 19, especially the vaccines.
Source: Bloomberg
Singapore is building up its vaccine manufacturing capacity in order to offer fill and finish contract manufacturing services to vaccine developers, Singapore Prime Minister Lee Hsien Loong said in published remarks delivered at a summit.
- The effort is aimed at helping companies ramp up production faster and assure them high standards of safety and quality in the manufacturing process, Lee said.
- The country is investing heavily in research and development on diagnostics, vaccines and therapeutics, he said.
- Singapore researchers have developed a range of serological and nucleic acid-based diagnostic tests, which have been deployed to over 20 countries.
- Researchers are also developing therapeutic monoclonal antibodies as well as a vaccine and have started clinical trials of various therapeutics, he added.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
Novavax starting human trial of its vaccine in Australia
Kaiser Permanente launches first coronavirus vaccine trial
Corona Fear’s Cure: Chanting from the Bible and the Quran
Can You Chant from the Bible or the Quran to Bliss and Happiness?
Japanese flu drug ‘clearly effective’ in treating coronavirus, says China
Synthetic antibodies might offer a quick coronavirus treatment
The Four Possible Timelines for Life Returning to Normal
The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic
Coronavirus: TB Vaccination Trial Started in Melbourne, Australia
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
All of humanity are intimate neighbors: Coronavirus proves it once again
Praise be to God for the Miracle of Our Immune System
USA: 15-minute coronavirus test is here
Does the Ordinary Soap Kill Coronavirus?
Here’s a list of disinfectants you can use against coronavirus
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE
Categories: Asia, Health, Singapore, The Muslim Times, Vaccine

As leading coronavirus vaccines make their way through early stages of human testing, the NIH is plotting much larger efficacy studies this summer. U.S. researchers plan to run phase 3 trials of vaccines from Moderna, AstraZeneca and Johnson & Johnson in the coming months, the Wall Street Journal reports.
The NIH intends to start a phase 3 trial of Moderna’s vaccine in July, followed by an August trial of AstraZeneca’s vaccine and a September study of Johnson & Johnson’s shot, a U.S. government researcher told the newspaper.
All three of the shots are based on brand-new technologies, and they’re all reportedly among finalists in the Operation Warp Speed program. Former FDA chief Scott Gottlieb has publicly questioned the picks, pointing out the team’s reliance on new technologies.
Johnson & Johnson has not previously disclosed any human testing for its vaccine and the company has previously said it’s aiming to enter human studies in September. But on Wednesday, the company said it’s accelerating its timeline, with plans to start a phase 1/2a study in July.
AstraZeneca and Moderna, meanwhile, are already in phase 2 testing. A Moderna representative confirmed the phase 3 plan to the Journal, and an AstraZeneca spokesperson said the company’s recent contract with the U.S. government includes a late-stage test, but the company didn’t confirm timing. AstraZeneca scored a whopping $1.2 billion COVID-19 vaccine contract from the U.S. last month.
https://www.fiercepharma.com/vaccines/nih-preps-late-stage-studies-moderna-az-and-j-j-coronavirus-vaccines-wsj